Validation of a composite vascular high-risk profile for adult patients with sickle cell disease.
作者信息
Nouraie Mehdi, Little Jane A, Hildesheim Mariana, Gibbs J Simon R, Morris Claudia R, Machado Roberto F, Kato Gregory J, Gordeuk Victor R, Gladwin Mark T
机构信息
Vascular Medicine Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
出版信息
Am J Hematol. 2019 Dec;94(12):E312-E314. doi: 10.1002/ajh.25624. Epub 2019 Sep 17.
Abstract
摘要
相似文献
1
Validation of a composite vascular high-risk profile for adult patients with sickle cell disease.
Am J Hematol. 2019 Dec;94(12):E312-E314. doi: 10.1002/ajh.25624. Epub 2019 Sep 17.
2
Reproducibility of tricuspid regurgitant jet velocity measurements in children and young adults with sickle cell disease undergoing screening for pulmonary hypertension.
Am J Hematol. 2010 Oct;85(10):741-5. doi: 10.1002/ajh.21793.
3
Hyperuricemia and abnormal nocturnal dipping impact glomerular filtration rate in patients with sickle cell anemia.
Am J Hematol. 2021 May 1;96(5):E143-E146. doi: 10.1002/ajh.26115. Epub 2021 Feb 18.
4
Pulmonary hypertension in children with sickle cell disease.
Expert Rev Respir Med. 2011 Apr;5(2):233-43. doi: 10.1586/ers.11.6.
5
Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia.
Blood. 2007 Jan 1;109(1):40-5. doi: 10.1182/blood-2006-02-005082. Epub 2006 Aug 29.
6
Pulmonary hypertension and NO in sickle cell.
Blood. 2010 Aug 5;116(5):852-4. doi: 10.1182/blood-2010-04-282095.
7
N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.
Hemoglobin. 2010;34(1):78-94. doi: 10.3109/03630260903554621.
8
The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom.
Br J Haematol. 2013 Aug;162(3):400-8. doi: 10.1111/bjh.12391. Epub 2013 May 29.
9
A pilot study of the effect of atorvastatin on endothelial function and albuminuria in sickle cell disease.
Am J Hematol. 2019 Nov;94(11):E299-E301. doi: 10.1002/ajh.25614. Epub 2019 Aug 22.
10
Mitral valve replacement in a child with sickle cell anemia.
J Thorac Cardiovasc Surg. 1972 May;63(5):797-9.
引用本文的文献
1
Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.
Lancet Haematol. 2024 May;11(5):e345-e357. doi: 10.1016/S2352-3026(24)00045-0. Epub 2024 Mar 27.
2
Exercise-induced changes of vital signs in adults with sickle cell disease.
Am J Hematol. 2021 Dec 1;96(12):1630-1638. doi: 10.1002/ajh.26369. Epub 2021 Oct 20.
3
Serum albumin is independently associated with higher mortality in adult sickle cell patients: Results of three independent cohorts.
PLoS One. 2020 Aug 10;15(8):e0237543. doi: 10.1371/journal.pone.0237543. eCollection 2020.
本文引用的文献
1
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
N Engl J Med. 2019 Aug 8;381(6):509-519. doi: 10.1056/NEJMoa1903212. Epub 2019 Jun 14.
2
cGMP modulation therapeutics for sickle cell disease.
Exp Biol Med (Maywood). 2019 Feb;244(2):132-146. doi: 10.1177/1535370219827276. Epub 2019 Jan 28.
3
Clustering of end-organ disease and earlier mortality in adults with sickle cell disease: A retrospective-prospective cohort study.
Am J Hematol. 2018 Sep;93(9):1153-1160. doi: 10.1002/ajh.25202. Epub 2018 Jul 30.
4
Intravascular hemolysis and the pathophysiology of sickle cell disease.
J Clin Invest. 2017 Mar 1;127(3):750-760. doi: 10.1172/JCI89741.
5
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.
N Engl J Med. 2017 Feb 2;376(5):429-439. doi: 10.1056/NEJMoa1611770. Epub 2016 Dec 3.
6
Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):207-15. doi: 10.2215/CJN.03940415. Epub 2015 Dec 15.
7
Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom.
PLoS One. 2014 Jul 2;9(7):e99489. doi: 10.1371/journal.pone.0099489. eCollection 2014.
8
N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.
JAMA. 2006 Jul 19;296(3):310-8. doi: 10.1001/jama.296.3.310.
9
Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
N Engl J Med. 2004 Feb 26;350(9):886-95. doi: 10.1056/NEJMoa035477.
10
Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.
J Pediatr. 2001 Dec;139(6):785-9. doi: 10.1067/mpd.2001.119593.
Zotero 插件